US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
ES8702440A1
(es)
|
1984-10-04 |
1986-12-16 |
Monsanto Co |
Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US5612059A
(en)
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
JPH072743B2
(ja)
|
1988-10-21 |
1995-01-18 |
富士写真フイルム株式会社 |
1H−ピラゾロ〔5,1−c〕−1,2,4−トリアゾール類およびピラゾール誘導体の製造方法
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
HU219131B
(hu)
|
1991-10-18 |
2001-02-28 |
Monsanto Co. |
Módszer és fungicid készítmény növények torsgombabetegségének gátlására és a hatóanyagok
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
HRP921338B1
(en)
|
1992-10-02 |
2002-04-30 |
Monsanto Co |
Fungicides for the control of take-all disease of plants
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US6274552B1
(en)
|
1993-03-18 |
2001-08-14 |
Cytimmune Sciences, Inc. |
Composition and method for delivery of biologically-active factors
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
US5523092A
(en)
|
1993-04-14 |
1996-06-04 |
Emory University |
Device for local drug delivery and methods for using the same
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
DE4405207A1
(de)
|
1994-02-18 |
1995-08-24 |
Bayer Ag |
N-Pyrazolylaniline und N-Pyrazolylaminopyridine
|
US5958458A
(en)
|
1994-06-15 |
1999-09-28 |
Dumex-Alpharma A/S |
Pharmaceutical multiple unit particulate formulation in the form of coated cores
|
MX9700068A
(es)
|
1994-06-24 |
1997-12-31 |
Euro Celtique Sa |
Compuestos y metodo para inhibir a la fosfodiesterasa iv.
|
US5922751A
(en)
|
1994-06-24 |
1999-07-13 |
Euro-Celtique, S.A. |
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
US5597826A
(en)
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
US6316652B1
(en)
|
1995-06-06 |
2001-11-13 |
Kosta Steliou |
Drug mitochondrial targeting agents
|
US5798119A
(en)
|
1995-06-13 |
1998-08-25 |
S. C. Johnson & Son, Inc. |
Osmotic-delivery devices having vapor-permeable coatings
|
ATE268591T1
(de)
|
1995-06-27 |
2004-06-15 |
Takeda Chemical Industries Ltd |
Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
US6039975A
(en)
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
EP0885890A1
(en)
|
1996-02-26 |
1998-12-23 |
Sumitomo Pharmaceuticals Company, Limited |
Sulfonylureidopyrazole derivatives
|
US5959109A
(en)
|
1996-05-15 |
1999-09-28 |
Neurocrine Biosciences, Inc. |
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
|
TW345603B
(en)
|
1996-05-29 |
1998-11-21 |
Gmundner Fertigteile Gmbh |
A noise control device for tracks
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
US6375987B1
(en)
|
1996-10-01 |
2002-04-23 |
Gattefossé, S.A. |
Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
|
EP1007012A4
(en)
|
1996-10-01 |
2006-01-18 |
Cima Labs Inc |
TASTE-MASKED MICRO-CAPSULE COMPOSITION AND MANUFACTURING PROCESS
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
EP0839525B1
(en)
|
1996-10-31 |
2004-08-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
DE19648576C2
(de)
|
1996-11-23 |
1999-08-12 |
Lohmann Therapie Syst Lts |
Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
|
EP0946169B1
(en)
|
1996-12-20 |
2003-02-26 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
US7169410B1
(en)
|
1998-05-19 |
2007-01-30 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
DK1126826T6
(en)
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
US6472416B1
(en)
|
1999-08-27 |
2002-10-29 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
|
CA2379421A1
(en)
|
1999-08-27 |
2001-03-08 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
|
AU780572B2
(en)
|
1999-10-18 |
2005-04-07 |
University Of Connecticut, The |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US7119108B1
(en)
|
1999-10-18 |
2006-10-10 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US8084467B2
(en)
|
1999-10-18 |
2011-12-27 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US7393842B2
(en)
|
2001-08-31 |
2008-07-01 |
University Of Connecticut |
Pyrazole analogs acting on cannabinoid receptors
|
CA2401697A1
(en)
|
2000-03-03 |
2001-09-07 |
Pfizer Products Inc. |
Pyrazole ether derivatives as anti-inflammatory/analgesic agents
|
US6623756B1
(en)
|
2000-04-27 |
2003-09-23 |
Noveon Ip Holdings Corp. |
Directly compressed solid dosage articles
|
CA2420535A1
(en)
|
2000-08-30 |
2002-03-07 |
Mary Tanya Am Ende |
Sustained release formulations for growth hormone secretagogues
|
US6468338B1
(en)
|
2000-10-12 |
2002-10-22 |
Eastman Kodak Company |
Dye for ink jet ink
|
US6464767B1
(en)
|
2000-10-12 |
2002-10-15 |
Eastman Kodak Company |
Ink jet printing method
|
BR0116411A
(pt)
|
2000-12-21 |
2003-11-11 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
DE10108480A1
(de)
|
2001-02-22 |
2002-09-05 |
Bayer Ag |
Pyrazolylpyrimidine
|
US6770645B2
(en)
|
2001-03-16 |
2004-08-03 |
Pfizer Inc. |
Pharmaceutically active compounds
|
GB0106661D0
(en)
|
2001-03-16 |
2001-05-09 |
Pfizer Ltd |
Pharmaceutically active compounds
|
US6593349B2
(en)
|
2001-03-19 |
2003-07-15 |
Icagen, Inc. |
Bisarylamines as potassium channel openers
|
JP2002309137A
(ja)
|
2001-04-12 |
2002-10-23 |
Fuji Photo Film Co Ltd |
インクジェット記録用インク組成物
|
US7132445B2
(en)
|
2001-04-16 |
2006-11-07 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
KR100952531B1
(ko)
|
2001-04-16 |
2010-04-12 |
쉐링 코포레이션 |
Cxc-케모카인 수용체 리간드로서의 3,4-이치환된사이클로부텐-1,2-디온
|
US20040106794A1
(en)
|
2001-04-16 |
2004-06-03 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
US20040097547A1
(en)
|
2001-04-16 |
2004-05-20 |
Taveras Arthur G. |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
EP1392684B1
(en)
|
2001-06-01 |
2006-09-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
DE60237826D1
(de)
|
2001-07-27 |
2010-11-11 |
Astellas Pharma Inc |
Zusammensetzung enthaltend feine Körner mit verzögerter Freisetzung für in der Mundhöhle schnell zerfallende Tabletten
|
AU2002331766A1
(en)
|
2001-08-31 |
2003-03-18 |
University Of Connecticut |
Novel pyrazole analogs acting on cannabinoid receptors
|
MXPA04002980A
(es)
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
|
CA2462862A1
(en)
|
2001-10-12 |
2003-04-17 |
Schering Corporation |
3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
|
CA2465207C
(en)
|
2001-11-01 |
2011-01-04 |
Icagen, Inc. |
Pyrazole-amides and -sulfonamides
|
WO2003037335A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
5-heteroatom-substituted pyrazoles
|
WO2003037336A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
|
BR0206441A
(pt)
|
2001-12-19 |
2003-12-30 |
Astrazeneca Ab |
Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação
|
HU229477B1
(en)
|
2001-12-24 |
2014-01-28 |
Astrazeneca Ab |
Substituted quinazoline derivatives as inhibitors of aurora kinases
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
US20040024085A1
(en)
|
2002-01-30 |
2004-02-05 |
Takahiro Ishizuka |
Ink composition and inkjet recording method
|
AU2003213628A1
(en)
|
2002-02-28 |
2003-09-16 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
US20040029887A1
(en)
|
2002-05-23 |
2004-02-12 |
Bhatia Pramila A. |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
US20030232836A1
(en)
|
2002-05-23 |
2003-12-18 |
Stewart Andrew O. |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
US20060009461A1
(en)
|
2002-05-23 |
2006-01-12 |
Bhatia Pramila A |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
WO2003099266A2
(en)
|
2002-05-23 |
2003-12-04 |
Abbott Laboratories |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
US6989451B2
(en)
|
2002-06-04 |
2006-01-24 |
Valeant Research & Development |
Heterocyclic compounds and uses thereof
|
AU2003295041A1
(en)
|
2002-11-20 |
2004-06-18 |
L'oreal |
Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof
|
FR2847160A1
(fr)
|
2002-11-20 |
2004-05-21 |
Oreal |
Composition capillaire contenant un compose pyrasol-carboxamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
|
US7485322B2
(en)
|
2002-12-24 |
2009-02-03 |
Lek Pharmaceuticals D.D. |
Modified release pharmaceutical composition
|
US20060270628A1
(en)
|
2003-04-29 |
2006-11-30 |
Jagattaran Das |
Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them
|
WO2004101531A1
(en)
|
2003-04-29 |
2004-11-25 |
Dr. Reddy's Laboratories Ltd. |
Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them
|
PT1631295E
(pt)
|
2003-06-06 |
2010-05-24 |
Arexis Ab |
Uso de compostos heterocíclicos condensados como inibidores de scce para o tratamento de doenças da pele
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
PL1644493T3
(pl)
|
2003-06-27 |
2010-11-30 |
Axikin Pharmaceuticals Inc |
Regulacja kinazy regulowanej w COPD (kinaza RC)
|
EP1654264A1
(en)
|
2003-07-08 |
2006-05-10 |
AstraZeneca AB |
Spiro [1-azabicyclo [2.2.2]octane-3,5'-oxazolidin-2'-one] derivatives with affinity to the alpha7 nicotinic acetylcholine receptor
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
CA2557575A1
(en)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Fused derivatives of pyrazole
|
MXPA06009462A
(es)
|
2004-02-27 |
2007-03-15 |
Hoffmann La Roche |
Derivados pirazolo heteroaril fusionados.
|
KR20050091462A
(ko)
|
2004-03-12 |
2005-09-15 |
한국과학기술연구원 |
푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
AU2005225471B2
(en)
|
2004-03-26 |
2011-05-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
WO2005099688A2
(en)
|
2004-04-07 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
US7033425B2
(en)
|
2004-04-15 |
2006-04-25 |
Eastman Kodak Company |
Ink jet ink set
|
US20090227648A1
(en)
|
2004-04-21 |
2009-09-10 |
Astrazeneca Ab |
Pyrazole derivatives useful for the treatment of cancer
|
US7399317B2
(en)
|
2004-08-26 |
2008-07-15 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
CN101018780B
(zh)
|
2004-08-26 |
2012-01-11 |
辉瑞大药厂 |
作为蛋白激酶抑制剂的吡唑取代的氨基杂芳基化合物
|
EP1789509B1
(en)
|
2004-09-01 |
2010-05-05 |
Dow Global Technologies Inc. |
Adhesion promoter
|
US7531560B2
(en)
|
2004-11-10 |
2009-05-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Anti-cytokine heterocyclic compounds
|
EP1812424A4
(en)
|
2004-11-17 |
2009-07-08 |
Miikana Therapeutics Inc |
Kinase Inhibitors
|
RS52061B
(en)
|
2005-02-04 |
2012-04-30 |
Astrazeneca Ab |
PIRAZOLYL-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS
|
WO2006087530A1
(en)
|
2005-02-16 |
2006-08-24 |
Astrazeneca Ab |
Chemical compounds
|
ES2347172T3
(es)
|
2005-02-16 |
2010-10-26 |
Astrazeneca Ab |
Compuestos quimicos.
|
TW200639073A
(en)
|
2005-03-29 |
2006-11-16 |
Mitsubishi Kagaku Media Co Ltd |
Optical recording medium, metal complex compound, and organic dye compound
|
WO2006115452A1
(en)
|
2005-04-27 |
2006-11-02 |
Astrazeneca Ab |
Use of pyrazolyl-pyrimidine derivatives in the treatment of pain
|
JP2008540391A
(ja)
|
2005-05-05 |
2008-11-20 |
アストラゼネカ アクチボラグ |
ピラゾリルアミノ置換ピリミジン、および癌の処置におけるそれらの使用
|
EP1912971A2
(en)
|
2005-06-29 |
2008-04-23 |
Shering Corporation |
Di-substituted oxadiazoles as cxc-chemokine receptor ligands
|
US7737151B2
(en)
|
2005-08-18 |
2010-06-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
WO2007023382A2
(en)
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
CN101316843B
(zh)
|
2005-11-03 |
2013-01-02 |
顶点医药品公司 |
用作激酶抑制剂的氨基嘧啶
|
CA2629781A1
(en)
|
2005-11-16 |
2007-05-24 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
AU2006320580B2
(en)
|
2005-11-30 |
2011-06-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Met and uses thereof
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
US7427414B2
(en)
|
2006-01-18 |
2008-09-23 |
Astron Research Limited |
Modified release oral dosage form using co-polymer of polyvinyl acetate
|
US7868177B2
(en)
|
2006-02-24 |
2011-01-11 |
Amgen Inc. |
Multi-cyclic compounds and method of use
|
GB0605691D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic Compounds
|
WO2008028140A1
(en)
|
2006-09-01 |
2008-03-06 |
Cv Therapeutics, Inc. |
Methods and compositions for increasing patient tolerability during myocardial imaging methods
|
US20090081120A1
(en)
|
2006-09-01 |
2009-03-26 |
Cv Therapeutics, Inc. |
Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
|
US20080064729A1
(en)
|
2006-09-07 |
2008-03-13 |
Millennium Pharmaceuticals, Inc. |
Phenethylamide derivatives with kinase inhibitory activity
|
CL2007003627A1
(es)
|
2006-12-15 |
2008-07-25 |
Bayer Schering Pharma Ag |
Compuestos derivados de 3-h-pirazolopiridinas; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades de crecimiento vascular desregulado tal como leucemia mielogena aguda, retinopatia, artritis reumatoide, psorias
|
EP2137158A4
(en)
|
2007-02-28 |
2012-04-18 |
Methylgene Inc |
LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
|
US7947698B2
(en)
|
2007-03-23 |
2011-05-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
AR068072A1
(es)
|
2007-04-19 |
2009-11-04 |
Novartis Ag |
Derivados de bencimidazoles, composiciones farmaceuticas y usos
|
US20090029992A1
(en)
|
2007-06-11 |
2009-01-29 |
Agoston Gregory E |
Substituted pyrazole compounds
|
WO2009032694A1
(en)
|
2007-08-28 |
2009-03-12 |
Dana Farber Cancer Institute |
Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis
|
SI2195312T1
(sl)
|
2007-10-09 |
2013-01-31 |
Merck Patent Gmbh |
Derivati piridina, uporabni kot aktivatorji glukokinaze
|
US20100292447A1
(en)
|
2007-10-12 |
2010-11-18 |
Merck Patent Gesellschaft |
Method and agent for refolding proteins
|
SG185996A1
(en)
|
2007-11-13 |
2012-12-28 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US20090143451A1
(en)
|
2007-11-14 |
2009-06-04 |
Andrews William H |
Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the same
|
WO2009073620A2
(en)
|
2007-11-30 |
2009-06-11 |
Newlink Genetics |
Ido inhibitors
|
JP5559702B2
(ja)
|
2008-02-25 |
2014-07-23 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコキナーゼ活性化剤
|
JP5117885B2
(ja)
|
2008-02-29 |
2013-01-16 |
富士フイルム株式会社 |
色素化合物、着色組成物、感熱転写記録用インクシート、感熱転写記録方法、カラートナー、インクジェット用インクおよびカラーフィルター
|
EP2265592A1
(en)
|
2008-03-14 |
2010-12-29 |
Basf Se |
Substituted pyraz inylmethyl sulfonamides for use as. fungicides
|
JP2009235122A
(ja)
|
2008-03-25 |
2009-10-15 |
Fujifilm Corp |
インク組成物、インクセット、及び画像記録方法
|
JP2011519357A
(ja)
|
2008-04-10 |
2011-07-07 |
ビーエーエスエフ ソシエタス・ヨーロピア |
置換ピリダジニルメチルスルホンアミド
|
TW201012803A
(en)
|
2008-06-06 |
2010-04-01 |
Organon Nv |
Heterocyclic derivatives
|
PT2959900T
(pt)
|
2008-06-16 |
2017-06-22 |
Univ Tennessee Res Found |
Composto para tratamento do cancro
|
JP5551689B2
(ja)
|
2008-06-17 |
2014-07-16 |
アストラゼネカ アクチボラグ |
ピリジン化合物
|
SI2315591T1
(sl)
|
2008-08-15 |
2016-06-30 |
Nivalis Therapeutics, Inc. |
Novi pirolni inhibitorji S-nitrozoglutation reduktaze kot terapevtska sredstva
|
US20100216827A1
(en)
|
2008-10-21 |
2010-08-26 |
Metabolex, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
US20110230536A1
(en)
|
2008-10-24 |
2011-09-22 |
Calcimedica, Inc. |
Phenylpyrazole inhibitors of store operated calcium release
|
EP2379684A2
(de)
|
2008-12-22 |
2011-10-26 |
Basf Se |
Mischungen hydrophober und hydrophiler ionischer flüssigkeiten und ihre verwendung in flüssigkeitsringverdichtern
|
JP2012518037A
(ja)
|
2009-02-18 |
2012-08-09 |
アムジエン・インコーポレーテツド |
mTORキナーゼ阻害剤としてのインドール/ベンゾイミダゾール化合物
|
PL2403499T3
(pl)
|
2009-03-02 |
2020-04-30 |
Stemsynergy Therapeutics, Inc. |
Sposoby i kompozycje do zastosowania w leczeniu raka i zmniejszaniu efektów w komórce, w których pośredniczy Wnt
|
FR2943057B1
(fr)
|
2009-03-12 |
2011-06-03 |
Centre Nat Rech Scient |
DERIVES DE 10-AMINO-1,2,3,4-TETRAHYDROPYRIDO°2,1-a!ISOINDOL-6(10bH)- ONES, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES
|
AR075858A1
(es)
|
2009-03-18 |
2011-05-04 |
Schering Corp |
Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
|
WO2010108115A1
(en)
|
2009-03-20 |
2010-09-23 |
Sanford-Burnham Medical Research Institute |
Allosteric jnk inhibitors
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
WO2011056895A1
(en)
|
2009-11-03 |
2011-05-12 |
University Of Notre Dame Du Lac |
Ionic liquids comprising heteraromatic anions
|
MX2012010115A
(es)
|
2010-03-01 |
2013-02-26 |
Gtx Inc |
Compuestos para el tratamiento de cancer.
|
EP2556066B1
(en)
*
|
2010-04-07 |
2016-10-19 |
F.Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
GB201010196D0
(en)
|
2010-06-17 |
2010-07-21 |
Respivert Ltd |
Methods
|
WO2012154880A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
|
CN104302640A
(zh)
|
2012-03-16 |
2015-01-21 |
埃克希金医药品有限公司 |
3,5-二氨基吡唑激酶抑制剂
|